12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

GlaxoSmithKline, Omega Pharma deal

GlaxoSmithKline will divest its non-core consumer healthcare OTC products in Europe to Omega for €470 million ($616.4 million) in cash. The brands had £185 million ($290 million) in...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >